# Ilaris

NDC: 0078-0734
Generic name: canakinumab
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20161222

FDA application: BLA125319

## Active ingredients

- CANAKINUMAB: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0734"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0734
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d271f3b-e4f9-4d80-8dcf-28d49123f80e